Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells ; day:26 ; month:06 ; year:2021 ; extent:10
Angewandte Chemie / International edition. International edition ; (26.06.2021) (gesamt 10)
- Creator
-
Xiao, Zhangping
Song, Shanshan
Chen, Deng
van Merkerk, Ronald
van der Wouden, Petra E.
Cool, Robbert H.
Quax, Wim J.
Poelarends, Gerrit
Melgert, Barbro N.
Dekker, Frank J.
- DOI
-
10.1002/anie.202101864
- URN
-
urn:nbn:de:101:1-2021062615253561239167
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xiao, Zhangping
- Song, Shanshan
- Chen, Deng
- van Merkerk, Ronald
- van der Wouden, Petra E.
- Cool, Robbert H.
- Quax, Wim J.
- Poelarends, Gerrit
- Melgert, Barbro N.
- Dekker, Frank J.
Other Objects (12)
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Anti-proliferative activity of silver nanoparticles
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Der anti-proliferative Effekt von Metformin bei humanen kolorektalen Karzinomzelllinien
Anti-proliferative activity of Artemisia marschalliana on cancerous cell lines
Anti-proliferative therapy for HIV cure: a compound interest approach
Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Anti-proliferative activity of silver nanoparticles
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Der anti-proliferative Effekt von Metformin bei humanen kolorektalen Karzinomzelllinien
Anti-proliferative activity of Artemisia marschalliana on cancerous cell lines
Anti-proliferative therapy for HIV cure: a compound interest approach
Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Anti-proliferative activity of silver nanoparticles
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Der anti-proliferative Effekt von Metformin bei humanen kolorektalen Karzinomzelllinien
Anti-proliferative activity of Artemisia marschalliana on cancerous cell lines
Anti-proliferative therapy for HIV cure: a compound interest approach